Low frataxin mRNA expression is associated with inflammation and oxidative stress in patients with type 2 diabetes

The mitochondrial protein frataxin is involved in iron metabolism, as well as regulation of oxidative stress. To elucidate the association of frataxin with the pathophysiology of diabetes, we evaluated the mRNA levels of frataxin in leukocytes of patients with type 2 diabetes (T2D). In addition, we investigated the relation between frataxin mRNA levels, inflammatory cytokines, and oxidative stress biomarkers.

[1]  M. Cooper,et al.  50 years forward: mechanisms of hyperglycaemia-driven diabetic complications , 2015, Diabetologia.

[2]  E. Feskens,et al.  Iron metabolism is prospectively associated with insulin resistance and glucose intolerance over a 7-year follow-up period: the CODAM study , 2015, Acta Diabetologica.

[3]  Kumar Sharma,et al.  Mitochondrial Hormesis and Diabetic Complications , 2015, Diabetes.

[4]  S. Legrand-Poels,et al.  Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. , 2014, Diabetes research and clinical practice.

[5]  B. Thorand,et al.  Association of iron indices and type 2 diabetes: a meta‐analysis of observational studies , 2014, Diabetes/metabolism research and reviews.

[6]  J. Fernández-Real,et al.  Effects of iron overload on chronic metabolic diseases. , 2014, The lancet. Diabetes & endocrinology.

[7]  G. Bennett,et al.  Mitotoxicity in distal symmetrical sensory peripheral neuropathies , 2014, Nature Reviews Neurology.

[8]  I. W. Moen,et al.  Iron: the hard player in diabetes pathophysiology , 2014, Acta physiologica.

[9]  S. McGee,et al.  The role of mitochondria in the aetiology of insulin resistance and type 2 diabetes. , 2014, Biochimica et biophysica acta.

[10]  M. Banerjee,et al.  Association of IL-6, TNF-α and IL-10 gene polymorphisms with type 2 diabetes mellitus , 2013, Molecular Biology Reports.

[11]  M. Igoillo-Esteve,et al.  Diabetes in Friedreich Ataxia , 2013, Journal of neurochemistry.

[12]  A. Dobrian,et al.  Islet inflammation: a unifying target for diabetes treatment? , 2013, Trends in Endocrinology & Metabolism.

[13]  Takanori Nagai,et al.  The mitochondrial protein frataxin is downregulated in hemodialysis patients , 2013, Clinical and Experimental Nephrology.

[14]  A. Koeppen,et al.  Central role and mechanisms of β‐cell dysfunction and death in friedreich ataxia–associated diabetes , 2012, Annals of neurology.

[15]  Marta A. Uzarska,et al.  The role of mitochondria in cellular iron-sulfur protein biogenesis and iron metabolism. , 2012, Biochimica et biophysica acta.

[16]  M. Banerjee,et al.  Interleukin-1 (IL-1) family of cytokines: role in type 2 diabetes. , 2012, Clinica chimica acta; international journal of clinical chemistry.

[17]  M. Panteghini,et al.  Diagnostic value of transferrin. , 2012, Clinica chimica acta; international journal of clinical chemistry.

[18]  R. Omdal,et al.  Improved detection of advanced oxidation protein products in plasma. , 2012, Clinica chimica acta; international journal of clinical chemistry.

[19]  U. Boggi,et al.  Evidence for a Role of Frataxin in Pancreatic Islets Isolated from Multi-Organ Donors with and Without Type 2 Diabetes Mellitus , 2012, Hormone and Metabolic Research.

[20]  V. Basevi,et al.  Standards of Medical Care in Diabetes—2012 , 2011, Diabetes Care.

[21]  J. Rains,et al.  Oxidative stress, insulin signaling, and diabetes. , 2011, Free radical biology & medicine.

[22]  S. Shoelson,et al.  Type 2 diabetes as an inflammatory disease , 2011, Nature Reviews Immunology.

[23]  P. Halban,et al.  Cytokine production by islets in health and diabetes: cellular origin, regulation and function , 2010, Trends in Endocrinology & Metabolism.

[24]  F. Hu,et al.  The role of iron in type 2 diabetes in humans. , 2009, Biochimica et biophysica acta.

[25]  S. Levi,et al.  The role of iron in mitochondrial function. , 2009, Biochimica et biophysica acta.

[26]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[27]  A. Pastore,et al.  The pathogenesis of Friedreich ataxia and the structure and function of frataxin , 2009, Journal of Neurology.

[28]  J. Sowers,et al.  Skeletal muscle insulin resistance: role of inflammatory cytokines and reactive oxygen species. , 2008, American journal of physiology. Regulatory, integrative and comparative physiology.

[29]  R. Curi,et al.  Diabetes associated cell stress and dysfunction: role of mitochondrial and non‐mitochondrial ROS production and activity , 2007, The Journal of physiology.

[30]  M. Stumvoll,et al.  Pathogenesis of Type 2 Diabetes , 2007, Endocrine research.

[31]  J. Wish.  Assessing iron status: beyond serum ferritin and transferrin saturation. , 2006, Clinical journal of the American Society of Nephrology : CJASN.

[32]  G. C. Ferreira,et al.  Mitochondrial iron detoxification is a primary function of frataxin that limits oxidative damage and preserves cell longevity. , 2006, Human molecular genetics.

[33]  T. Stemmler,et al.  The Structure and Function of Frataxin , 2006, Critical reviews in biochemistry and molecular biology.

[34]  O. Erel,et al.  A new automated colorimetric method for measuring total oxidant status. , 2005, Clinical biochemistry.

[35]  O. Erel,et al.  Increased oxidative stress in infants exposed to passive smoking , 2005, European Journal of Pediatrics.

[36]  C. Lindgren,et al.  Haplotype construction of the FRDA gene and evaluation of its role in type II diabetes , 2005, European Journal of Human Genetics.

[37]  J. Leahy.  Pathogenesis of type 2 diabetes mellitus. , 2005, Archives of medical research.

[38]  K. Petersen,et al.  Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. , 2004, The New England journal of medicine.

[39]  O. Erel.  A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. , 2003, Clinical biochemistry.

[40]  M. Koenig,et al.  Frataxin deficiency in pancreatic islets causes diabetes due to loss of beta cell mass. , 2003, The Journal of clinical investigation.

[41]  A. Symeonidis,et al.  Relative iron "overload" in offspring of patients with type 2 diabetes mellitus: a new component in the conundrum of insulin resistance syndrome? , 2003, Hormones.

[42]  J. Eaton,et al.  Molecular bases of cellular iron toxicity. , 2002, Free radical biology & medicine.

[43]  A. D. de Craen,et al.  Low production capacity of interleukin-10 associates with the metabolic syndrome and type 2 diabetes : the Leiden 85-Plus Study. , 2002, Diabetes.

[44]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[45]  M. Kibata,et al.  Relationship between serum tumor necrosis factor-α and insulin resistance in obese men with Type 2 diabetes mellitus , 2001 .

[46]  J. Dichgans,et al.  Oxidative stress in patients with Friedreich ataxia , 2000, Neurology.

[47]  C. Kahn,et al.  Frataxin activates mitochondrial energy conversion and oxidative phosphorylation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[48]  L. Schöls,et al.  Heterozygous expansion of the GAA tract of the X25/frataxin gene is associated with insulin resistance in humans. , 2000, Diabetes.

[49]  D J Newman,et al.  Urinary protein and albumin excretion corrected by creatinine and specific gravity. , 2000, Clinica chimica acta; international journal of clinical chemistry.

[50]  O. Pedersen,et al.  Intermediate expansions of a GAA repeat in the frataxin gene are not associated with type 2 diabetes or altered glucose-induced beta-cell function in Danish Caucasians. , 1999, Diabetes.

[51]  J. Dekker,et al.  Altered beta-cell characteristics in impaired glucose tolerant carriers of a GAA trinucleotide repeat polymorphism in the frataxin gene. , 1999, Diabetes.

[52]  M. Vorgerd,et al.  An association between NIDDM and a GAA trinucleotide repeat polymorphism in the X25/frataxin (Friedreich's ataxia) gene. , 1998, Diabetes.

[53]  Michel Koenig,et al.  Studies of human, mouse and yeast homologues indicate a mitochondrial function for frataxin , 1997, Nature Genetics.

[54]  G. Finocchiaro,et al.  Glucose metabolism alterations in Friedreich's ataxia , 1988, Neurology.

[55]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[56]  M. Cooper,et al.  Mechanisms of diabetic complications. , 2013, Physiological reviews.

[57]  A. Aljada,et al.  Inflammation: the link between insulin resistance, obesity and diabetes. , 2004, Trends in immunology.